TABLE 1

Results Using 111In-Octreotide Scintigraphy and 18F-FDG PET Scanning (n = 38 Patients)

ModalityPET+*PET−Total
111In-octreotide scintigraphy (positive)7 (2†)2027
111In-octreotide scintigraphy (negative)8 (2†)311
Total152338

  • ↵* T/NT ≥ 2.5.

  • ↵† High-grade tumor according to WHO/ENETS classification.